Figure 1 Representation of a biosafety cabinet with seven sampling spots highlighted: (a) left and right sleeves; (b) work bench; (c) scale plate; (d)

Slides:

Advertisements

Similar presentations

Controlling Exposures to Prevent occupational lung disease in the construction industry Controlling Exposures to Prevent.

Advertisements

© Oxford University Press How are the plates moving?

Fig. 3. Plot of overall survival by adjuvant therapy for patient subgroups. (A) Patients with M0 disease (n = 411). (B) Patients receiving 36 Gy craniospinal.

USP 800 Implementation in a Community Oncology Practice

Fig. 1 Flow chart of the COBRA-light trial and its extension study

Figure 1 Growth of nurse education programme since 1991 (SN, B. N

Figure 1. Flow diagram of participants recruited into the study.

Figure 2. Quality of life (QOL) scores for functional scale items

Figure 1. FinHER dataset: distribution of tumor-infiltrating lymphocytes in breast cancer according to the (A) three breast cancer subtypes and (B) HER2.

Fig. 3 Evolutionary game types as a function of relatedness and synergy where each plot is a different social group size. The payoffs used to generate.

Figure 1. Study area south of Milne Point, Alaska, where artificial den forward-looking infrared sampling took place in March From: Factors Influencing.

Figure 1. Left: model of the steel lattice mast with FM dipoles located close to the ladder (first two configurations). Right: model of the steel pole.

From: Blue-Light Hazard From Gas Metal Arc Welding of Aluminum Alloys

Figure 1. Typical cursor trajectory of users with CP with poorly developed fine motor control during a pointing task. From: A Novel Head Cursor Facilitation.

Fig 1. Go To Work On An Egg poster, by Ogilvy, Benson & Mather, 1960s

Figure 1. Logos appearing in the choice experiment

Figure 1. Selection of papers.

Figure 1. Conceptual model of well-being related to involvement in theatre. From: Theatre Involvement and Well-Being, Age Differences, and Lessons From.

Figure 1. (A) Forest plot of common odds ratios (adjusted for ECOG PS) for best overall response by a priori subgroups in patients with KRAS wild-type.

Figure 1. Hepatitis B surface antigen (HBsAg) testing uptake and results among women delivering at Bairo Pite Clinic in Dili, Timor-Leste. From: Prevalence.

Figure 3 SEM images of airborne agglomerates of MWCNTs collected in the breathing zone of the worker in the production laboratory with a Siorutas Personal.

Open Forum Infect Dis. 2014;1(suppl_1):S13-S14. doi: /ofid/ofu051.37

Source: Authors’ elaboration with data from Eurostat.

Figure 1 Measured personal respirable dust versus respirable crystalline silica results collected in the SCL environment. Lines show recommended BOHS and.

From: Where do we go from here

Figure 1. Single-Tree Model and BART Fits to Simulated Data.

Figure 1. Distribution of pivot[N] from the Cricklewood experiment (M = N). Solid circles include all the data, whereas open circles refer to N < 5, and.

Figure 1. Time of initiation of therapeutic hypothermia according to who initiated it. Note the logarithmic scaling of the vertical axis. From: Initiation.

Figure 1: Time points at which sperm samples were analysed for aneuploidy frequencies in controls and cancer patients From: Sperm aneuploidy frequencies.

Figure 3. Visualisation of ESMO-MCB scores for curative and non-curative setting. A & B and 5 and 4 represent the grades with substantial improvement.

Figure 1. Dosage and administration route of drugs used in the BMD study. Each cycle was proposed every 28 days (‘base’ schedule) or 35 days (‘weekly’

Figure 6. RRs for clinical cure rates stratified by different diseases

Figure 1. Progression-free survival and overall survival for FL/DLBCL patients. From: Clinicobiological features and prognostic impact of diffuse large.

Figure 1. HR (95% CI) of death from dementia associated with weight or BMI in middle age and in old age. From: Adiposity in middle and old age and risk.

Figure 3 Doctors leaving (Matthews, 2013, p.13.)

Figure 1 Flow diagram detailing the systematic review process.

Figure 1. Plasma next-generation sequencing (NGS) assay workflow, comparison of variant allelic fraction with ... Figure 1. Plasma next-generation sequencing.

Figure 1 Schematic representation of the experimental design.

(A) Calcinosis cutis on the extensor side of the left upper arm ...

Figure 1 Qualitative analysis—themes and subthemes regarding detention minimisation Unless provided in the caption above, the following copyright applies.

Figure 1 Phases of the research. Author’s own work.

Figure 1. Linkage analyses of the SNPs in the MRE11 gene and haplotype blocks. Haplotype blocks were defined for all ... Figure 1. Linkage analyses of.

Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.

Figure 1. SpeI-PFGE dendrogram comparing P

Fig. 1 MRI aspect of an osteitis of the left acetabulum at baseline (A), 3 months (B), 1 year (C) and 2 years later, ... Fig. 1 MRI aspect of an osteitis.

A. PMPs; B. endotheliocyte-derived MPs; C. leukocyte-derived MPs

Fig. 1 Subacute cutaneous lupus erythematous at the lower limbs

Fig. 1 Flow chart of included patients for analyses

Fig. 1 Flow chart for selection of study subjects

Figure 1 Plot showing the interaction between Indigenous group belonging and use of family health centres Figure 1 Plot showing the interaction between.

Figure 1. Susceptibility of all P

Figure 1. (a) Geographical representation of sample collection area

Figure 1 Relationships between pair indices of dance performance (joint entropy or mutual information) and the past ... Figure 1 Relationships between.

Figure 1. Flow diagram for selection of articles for systematic review. Unless provided in the caption above, the following copyright applies to the content.

Figure 1. Time–kill studies for selected isolates (each line represents the average of duplicate studies). AMP, ... Figure 1. Time–kill studies for selected.

Figure 1 Immunohistochemistry for human cell differentiation molecules in samples of the right ventricular septum from ... Figure 1 Immunohistochemistry.

Figure 1 MIC test strips showing reversion of daptomycin resistance of isolate 5 passaged in vitro. This figure ... Figure 1 MIC test strips showing reversion.

Figure 1. Trunk and leg fat over study period. LS, log transformed.

Fig. 1 Kaplan-Meier plot presenting no difference in progression to RA in patients with clinically suspect ... Fig. 1 Kaplan-Meier plot presenting no difference.

Figure 1. Oncoprint of selected pathogenic alterations detected in ctDNA. Unless provided in the caption above, the following copyright applies to the.

Figure 2. (a) Geometric mean (%CV) tenofovir diphosphate concentrations (TFV-DP in fmol/punch) in dried blood spot ... Figure 2. (a) Geometric mean (%CV)

Figure 1. Biofilm susceptibility to antibiotic treatment

Figure 1 Grant agencies and charitable foundations supporting Plan S.

Normalized radial cumulative stellar mass distribution centred on the BCG (left-hand panel) and the MMCG (right-hand panel) for the MCXC/SDSS comparison.

Figure 1 Strategies for reconciling protection and participation.

Figure 1 ABCDE of primary prevention.2

Figure 1. Forest plot of lung cancer mortality in LDCT trials.

Figure 1. Kaplan–Meier curves showing the impact of the different pretreatment HIV-1 drug resistance categories on the ... Figure 1. Kaplan–Meier curves.

Presentation transcript:

Figure 1 Representation of a biosafety cabinet with seven sampling spots highlighted: (a) left and right sleeves; (b) work bench; (c) scale plate; (d) CATO mouse or keyboard; (e) left and right airlock handles. From: Efficacy of Two Cleaning Solutions for the Decontamination of 10 Antineoplastic Agents in the Biosafety Cabinets of a Hospital Pharmacy Ann Occup Hyg. 2015;59(7):895-908. doi:10.1093/annhyg/mev031 Ann Occup Hyg | © The Author 2015. Published by Oxford University Press on behalf of the British Occupational Hygiene Society.

Figure 2 Relationship between the quantities of the 10 antineoplastic agents introduced in the BSC for the chemotherapy preparations and the quantities detected (Q) before the cleaning procedure. BSC 1) y = 5.9948 x + 33218, R<sup>2</sup> = 0.059; BSC 2) y = −0.3824x + 39772, R<sup>2</sup> = 0.0003. From: Efficacy of Two Cleaning Solutions for the Decontamination of 10 Antineoplastic Agents in the Biosafety Cabinets of a Hospital Pharmacy Ann Occup Hyg. 2015;59(7):895-908. doi:10.1093/annhyg/mev031 Ann Occup Hyg | © The Author 2015. Published by Oxford University Press on behalf of the British Occupational Hygiene Society.

Figure 3 Contamination rate over view in terms of Σ<sub>Q</sub> of all antineoplastics and efficacy histograms are plotted according to the wiping campaigns. From: Efficacy of Two Cleaning Solutions for the Decontamination of 10 Antineoplastic Agents in the Biosafety Cabinets of a Hospital Pharmacy Ann Occup Hyg. 2015;59(7):895-908. doi:10.1093/annhyg/mev031 Ann Occup Hyg | © The Author 2015. Published by Oxford University Press on behalf of the British Occupational Hygiene Society.

Figure 4 Efficacy of cleaning solutions on 10 antineoplastic agents in BSC 1 and BSC 2 during the study, with P value results of Fisher–Student test in brackets. From: Efficacy of Two Cleaning Solutions for the Decontamination of 10 Antineoplastic Agents in the Biosafety Cabinets of a Hospital Pharmacy Ann Occup Hyg. 2015;59(7):895-908. doi:10.1093/annhyg/mev031 Ann Occup Hyg | © The Author 2015. Published by Oxford University Press on behalf of the British Occupational Hygiene Society.